Blog: Nestle receives green light on Pfizer deal

Michelle Russell | 6 November 2012

Swiss food group Nestle today (6 November) received approval from the Chinese Ministry of Commerce for its US$11.85bn deal to acquire Pfizer's infant nutrition business.

The approval brings Nestle another step closer to completing the acquisition, which was announced in April this year, enabling the world's largest infant nutrition group to extend its lead in this fast-growing category.

Pfizer Nutrition operates in more than 60 countries globally and 85% of sales are generated in emerging markets, meaning the acquisition effectively fills in the blanks on the map for Nestle. It will provide the company with increased scale in a high-growth, high-margin, category in fast-growing developing markets, CEO Paul Bulcke told investors as it emerged as victor of competitive auction process.

Nestle beat companies including Danone and Mead Johnson to seal the agreement. The next hurdle, however, is to receive approval from anti-trust bodies in several countries in order to fully complete the acquisition.


Osborne overplays Britishness of United Biscuits

That politicians are selective with the truth is pretty much a given. But it did make this pundit chuckle to hear UK Chancellor George Osborne describe United Biscuits as a "great British company"... ...


Globally, consumers are dining out again, says NPD Group

Researchers at US-based The NPD Group have expressed optimism in the prospects for the foodservice sector after analysing sales data in 11 markets this summer....


Maggi returns but will growth follow in AOA for Nestle?

Nestle had some reason for cheer this week when it was confirmed that Maggi noodles should be back on Indian shelves this month....

just-food homepage

Forgot your password?